Annual Cash & Cash Equivalents
$966.00 M
+$191.00 M+24.65%
31 December 2023
Summary:
Colgate-Palmolive annual cash & cash equivalents is currently $966.00 million, with the most recent change of +$191.00 million (+24.65%) on 31 December 2023. During the last 3 years, it has risen by +$134.00 million (+16.11%). CL annual cash & cash equivalents is now -37.07% below its all-time high of $1.53 billion, reached on 31 December 2017.CL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$1.23 B
+$124.00 M+11.17%
30 September 2024
Summary:
Colgate-Palmolive quarterly cash and cash equivalents is currently $1.23 billion, with the most recent change of +$124.00 million (+11.17%) on 30 September 2024. Over the past year, it has increased by +$268.00 million (+27.74%). CL quarterly cash and cash equivalents is now -31.25% below its all-time high of $1.79 billion, reached on 31 March 2014.CL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CL Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +27.7% |
3 y3 years | +16.1% | +48.3% |
5 y5 years | +9.4% | +39.8% |
CL Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +24.6% | at high | +59.2% |
5 y | 5 years | at high | +24.6% | at high | +59.2% |
alltime | all time | -37.1% | +1591.8% | -31.3% | +2061.1% |
Colgate-Palmolive Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.23 B(+11.2%) |
June 2024 | - | $1.11 B(+2.9%) |
Mar 2024 | - | $1.08 B(+11.7%) |
Dec 2023 | $966.00 M(+24.6%) | $966.00 M(+1.6%) |
Sept 2023 | - | $951.00 M(+16.1%) |
June 2023 | - | $819.00 M(-5.5%) |
Mar 2023 | - | $867.00 M(+11.9%) |
Dec 2022 | $775.00 M(-6.9%) | $775.00 M(-17.4%) |
Sept 2022 | - | $938.00 M(+9.3%) |
June 2022 | - | $858.00 M(-2.2%) |
Mar 2022 | - | $877.00 M(+5.4%) |
Dec 2021 | $832.00 M(-6.3%) | $832.00 M(-13.2%) |
Sept 2021 | - | $958.00 M(+2.2%) |
June 2021 | - | $937.00 M(-5.8%) |
Mar 2021 | - | $995.00 M(+12.0%) |
Dec 2020 | $888.00 M(+0.6%) | $888.00 M(-10.2%) |
Sept 2020 | - | $989.00 M(-0.8%) |
June 2020 | - | $997.00 M(+16.7%) |
Mar 2020 | - | $854.00 M(-3.3%) |
Dec 2019 | $883.00 M(+21.6%) | $883.00 M(-6.9%) |
Sept 2019 | - | $948.00 M(+9.8%) |
June 2019 | - | $863.00 M(+2.4%) |
Mar 2019 | - | $843.00 M(+16.1%) |
Dec 2018 | $726.00 M(-52.7%) | $726.00 M(-13.7%) |
Sept 2018 | - | $841.00 M(+1.0%) |
June 2018 | - | $833.00 M(-2.1%) |
Mar 2018 | - | $851.00 M(-44.6%) |
Dec 2017 | $1.53 B(+16.7%) | $1.53 B(+11.2%) |
Sept 2017 | - | $1.38 B(+11.2%) |
June 2017 | - | $1.24 B(-7.9%) |
Mar 2017 | - | $1.35 B(+2.4%) |
Dec 2016 | $1.31 B(+35.6%) | $1.31 B(+1.3%) |
Sept 2016 | - | $1.30 B(+19.6%) |
June 2016 | - | $1.08 B(+7.0%) |
Mar 2016 | - | $1.01 B(+4.5%) |
Dec 2015 | $970.00 M(-10.9%) | $970.00 M(-32.9%) |
Sept 2015 | - | $1.45 B(+36.4%) |
June 2015 | - | $1.06 B(+23.3%) |
Mar 2015 | - | $859.00 M(-21.1%) |
Dec 2014 | $1.09 B(+13.2%) | $1.09 B(-19.6%) |
Sept 2014 | - | $1.35 B(+16.7%) |
June 2014 | - | $1.16 B(-35.3%) |
Mar 2014 | - | $1.79 B(+86.6%) |
Dec 2013 | $962.00 M(+8.8%) | $962.00 M(+33.4%) |
Sept 2013 | - | $721.00 M(-18.4%) |
June 2013 | - | $884.00 M(-5.2%) |
Mar 2013 | - | $932.00 M(+5.4%) |
Dec 2012 | $884.00 M(+0.7%) | $884.00 M(-2.8%) |
Sept 2012 | - | $909.00 M(-8.6%) |
June 2012 | - | $995.00 M(-4.7%) |
Mar 2012 | - | $1.04 B(+18.9%) |
Dec 2011 | $878.00 M(+79.2%) | $878.00 M(-7.1%) |
Sept 2011 | - | $945.00 M(+27.9%) |
June 2011 | - | $739.00 M(+7.7%) |
Mar 2011 | - | $686.00 M(+40.0%) |
Dec 2010 | $490.00 M(-18.3%) | $490.00 M(-12.7%) |
Mar 2010 | - | $561.00 M(-6.5%) |
Dec 2009 | $600.00 M(+8.1%) | $600.00 M(-29.2%) |
Sept 2009 | - | $847.00 M(-5.5%) |
June 2009 | - | $896.00 M(+27.6%) |
Mar 2009 | - | $702.20 M(+26.5%) |
Dec 2008 | $555.00 M(+29.5%) | $555.00 M(-12.6%) |
Sept 2008 | - | $634.70 M(+1.9%) |
June 2008 | - | $622.80 M(-3.0%) |
Mar 2008 | - | $642.10 M(+49.8%) |
Dec 2007 | $428.70 M(-12.4%) | $428.70 M(-31.8%) |
Sept 2007 | - | $628.40 M(+14.9%) |
June 2007 | - | $546.90 M(+15.3%) |
Mar 2007 | - | $474.40 M(-3.1%) |
Dec 2006 | $489.50 M | $489.50 M(-2.7%) |
Sept 2006 | - | $502.90 M(+16.8%) |
June 2006 | - | $430.40 M(+12.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2006 | - | $382.80 M(+12.4%) |
Dec 2005 | $340.70 M(+6.6%) | $340.70 M(-9.5%) |
Sept 2005 | - | $376.30 M(-4.0%) |
June 2005 | - | $392.10 M(-5.3%) |
Mar 2005 | - | $413.90 M(+29.5%) |
Dec 2004 | $319.60 M(+20.5%) | $319.60 M(-13.8%) |
Sept 2004 | - | $370.60 M(-11.2%) |
June 2004 | - | $417.30 M(+53.7%) |
Mar 2004 | - | $271.50 M(+2.3%) |
Dec 2003 | $265.30 M(+58.0%) | $265.30 M(+3.6%) |
Sept 2003 | - | $256.10 M(+16.8%) |
June 2003 | - | $219.20 M(+6.5%) |
Mar 2003 | - | $205.80 M(+22.6%) |
Dec 2002 | $167.90 M(-2.8%) | $167.90 M(-16.3%) |
Sept 2002 | - | $200.70 M(-18.9%) |
June 2002 | - | $247.40 M(+33.9%) |
Mar 2002 | - | $184.80 M(+7.0%) |
Dec 2001 | $172.70 M(-16.4%) | $172.70 M(-40.4%) |
Sept 2001 | - | $289.60 M(+15.3%) |
June 2001 | - | $251.10 M(+10.2%) |
Mar 2001 | - | $227.90 M(+10.3%) |
Dec 2000 | $206.60 M(+3.5%) | $206.60 M(-2.0%) |
Sept 2000 | - | $210.90 M(-5.9%) |
June 2000 | - | $224.20 M(+8.6%) |
Mar 2000 | - | $206.40 M(+3.4%) |
Dec 1999 | $199.60 M(+9.9%) | $199.60 M(-24.0%) |
Sept 1999 | - | $262.50 M(+32.5%) |
June 1999 | - | $198.10 M(+4.8%) |
Mar 1999 | - | $189.00 M(+4.0%) |
Dec 1998 | $181.70 M(-0.8%) | $181.70 M(-13.5%) |
Sept 1998 | - | $210.00 M(+19.3%) |
June 1998 | - | $176.10 M(-0.1%) |
Mar 1998 | - | $176.20 M(-3.8%) |
Dec 1997 | $183.10 M(-26.2%) | $183.10 M(-19.5%) |
Sept 1997 | - | $227.40 M(-2.9%) |
June 1997 | - | $234.30 M(+40.0%) |
Mar 1997 | - | $167.30 M(-32.6%) |
Dec 1996 | $248.20 M(+18.9%) | $248.20 M(+11.5%) |
Sept 1996 | - | $222.70 M(+17.3%) |
June 1996 | - | $189.80 M(-8.3%) |
Mar 1996 | - | $206.90 M(-0.9%) |
Dec 1995 | $208.80 M(+22.9%) | $208.80 M(-6.8%) |
Sept 1995 | - | $224.00 M(+35.4%) |
June 1995 | - | $165.40 M(-3.6%) |
Mar 1995 | - | $171.50 M(+0.9%) |
Dec 1994 | $169.90 M(+17.9%) | $169.90 M(-6.1%) |
Sept 1994 | - | $180.90 M(+18.6%) |
June 1994 | - | $152.50 M(+3.1%) |
Mar 1994 | - | $147.90 M(+2.6%) |
Dec 1993 | $144.10 M(+22.2%) | $144.10 M(-15.4%) |
Sept 1993 | - | $170.30 M(+12.8%) |
June 1993 | - | $151.00 M(-14.1%) |
Mar 1993 | - | $175.70 M(+49.0%) |
Dec 1992 | $117.90 M(-30.0%) | $117.90 M(-30.9%) |
Sept 1992 | - | $170.50 M(+0.2%) |
June 1992 | - | $170.20 M(-16.0%) |
Mar 1992 | - | $202.60 M(+20.2%) |
Dec 1991 | $168.50 M(+1.3%) | $168.50 M(+31.1%) |
Sept 1991 | - | $128.50 M(+2.4%) |
June 1991 | - | $125.50 M(-5.4%) |
Mar 1991 | - | $132.70 M(-20.3%) |
Dec 1990 | $166.40 M(-58.2%) | $166.40 M(+30.6%) |
Sept 1990 | - | $127.40 M(-30.4%) |
June 1990 | - | $183.10 M(-23.3%) |
Mar 1990 | - | $238.70 M(-40.0%) |
Dec 1989 | $397.90 M(+8.9%) | $397.90 M(+86.6%) |
Sept 1989 | - | $213.20 M(-41.7%) |
Dec 1988 | $365.50 M(+540.1%) | $365.50 M(+540.1%) |
Dec 1987 | $57.10 M(-65.4%) | $57.10 M(-65.4%) |
Dec 1986 | $165.10 M(-36.4%) | $165.10 M(-36.4%) |
Dec 1985 | $259.50 M(-26.2%) | $259.50 M(-26.2%) |
Dec 1984 | $351.70 M | $351.70 M |
FAQ
- What is Colgate-Palmolive annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Colgate-Palmolive?
- What is Colgate-Palmolive quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Colgate-Palmolive?
- What is Colgate-Palmolive quarterly cash and cash equivalents year-on-year change?
What is Colgate-Palmolive annual cash & cash equivalents?
The current annual cash & cash equivalents of CL is $966.00 M
What is the all time high annual cash & cash equivalents for Colgate-Palmolive?
Colgate-Palmolive all-time high annual cash & cash equivalents is $1.53 B
What is Colgate-Palmolive quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CL is $1.23 B
What is the all time high quarterly cash and cash equivalents for Colgate-Palmolive?
Colgate-Palmolive all-time high quarterly cash and cash equivalents is $1.79 B
What is Colgate-Palmolive quarterly cash and cash equivalents year-on-year change?
Over the past year, CL quarterly cash and cash equivalents has changed by +$268.00 M (+27.74%)